Increase in lobular breast cancer incidence in Switzerland
Corresponding Author
Fabio Levi
Cancer Epidemiology Unit and Cancer Registries of Vaud and Neuchâtel, Institut Universitaire de Médecine Sociale et Préventive, Lausanne, Switzerland
Fax: +004121-3230303
Cancer Registry of Vaud, Institut Universitaire de Médecine Sociale et Préventive, CHUV-Falaises 1, 1011 Lausanne, SwitzerlandSearch for more papers by this authorVan-Cong Te
Cancer Epidemiology Unit and Cancer Registries of Vaud and Neuchâtel, Institut Universitaire de Médecine Sociale et Préventive, Lausanne, Switzerland
Search for more papers by this authorLalao Randimbison
Cancer Epidemiology Unit and Cancer Registries of Vaud and Neuchâtel, Institut Universitaire de Médecine Sociale et Préventive, Lausanne, Switzerland
Search for more papers by this authorCarlo La Vecchia
Cancer Epidemiology Unit and Cancer Registries of Vaud and Neuchâtel, Institut Universitaire de Médecine Sociale et Préventive, Lausanne, Switzerland
Laboratory of Epidemiology, Istituto di Ricerche Farmacologiche ‘Mario Negri’, Milan, Italy
Istituto di Statistica Medica e Biometria, Università degli Studi di Milano, Milan, Italy
Search for more papers by this authorCorresponding Author
Fabio Levi
Cancer Epidemiology Unit and Cancer Registries of Vaud and Neuchâtel, Institut Universitaire de Médecine Sociale et Préventive, Lausanne, Switzerland
Fax: +004121-3230303
Cancer Registry of Vaud, Institut Universitaire de Médecine Sociale et Préventive, CHUV-Falaises 1, 1011 Lausanne, SwitzerlandSearch for more papers by this authorVan-Cong Te
Cancer Epidemiology Unit and Cancer Registries of Vaud and Neuchâtel, Institut Universitaire de Médecine Sociale et Préventive, Lausanne, Switzerland
Search for more papers by this authorLalao Randimbison
Cancer Epidemiology Unit and Cancer Registries of Vaud and Neuchâtel, Institut Universitaire de Médecine Sociale et Préventive, Lausanne, Switzerland
Search for more papers by this authorCarlo La Vecchia
Cancer Epidemiology Unit and Cancer Registries of Vaud and Neuchâtel, Institut Universitaire de Médecine Sociale et Préventive, Lausanne, Switzerland
Laboratory of Epidemiology, Istituto di Ricerche Farmacologiche ‘Mario Negri’, Milan, Italy
Istituto di Statistica Medica e Biometria, Università degli Studi di Milano, Milan, Italy
Search for more papers by this author
REFERENCES
- 1 Verkooijen HM, Fioretta G, Vlastos G, Morabia A, Schubert H, Sappino AP, Pelte M-F, Schäfer P, Kurtz J, Bouchardy C. Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland. Int J Cancer 2003; 104: 778–81.
- 2 Li CI, Anderson BO, Daling JR, Moe RE. Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 2003; 289: 1421–4.
- 3 World Health Organization. ICD-O. International classification of diseases for oncology. 1st ed. Geneva: WHO, 1976.
- 4 Levi F, Te VC, Randimbison L, La Vecchia C. Statistics from the Registry of the Canton of Vaud, Switzerland, 1988–1992. In: DM Parkin, S Whelan, J Ferlay, L Raymond, J Young, eds. Cancer incidence in five continents, vol. IARC: Lyon, 1997.
- 5 Bulliard J-L, De Landtsheer J-P, Levi F. Results from the Swiss mammography screening pilot programme. Eur J Cancer (in press).
- 6
Levi F,
Te VC,
Randimbison L,
La Vecchia C.
Trends in cancer incidence and mortality in Vaud, Switzerland, 1974-1993.
Ann Oncol
1996;
7:
407–504.
10.1093/oxfordjournals.annonc.a010639 Google Scholar
- 7
Li CI,
Weiss NS,
Stanford JL,
Daling JR.
Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women.
Cancer
2000;
88:
2570–7.
10.1002/1097-0142(20000601)88:11<2570::AID-CNCR20>3.0.CO;2-O CAS PubMed Web of Science® Google Scholar
- 8 Newcomer LM, Newcomb PA, Daling R, Yasul Y, Potter JD. Post-menopausal hormone use and risk of breast cancer by histologic type. Am J Epidemiol 1999; 149: S79.
- 9 Chen CL, Weiss NS, Newcomb P, Barlow W, White E. Hormone replacement therapy in relation to breast cancer. JAMA 2002; 287: 734–41.
- 10 Newcomb PA, Titus-Ernstoff L, Egan KM, Trentham-Dietz A, Baron JA, Storer BE, Willett WC, Stampfer MT. Post-menopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev 2002; 11: 593–600.
- 11 Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Coates RJ, Marchbanks PA, Norman SA, Weiss LK, Ursin G, Berlin JA, Burkman RT. Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma. Cancer 2002; 95: 2455–64.
- 12 La Vecchia C, Brinton L, McTiernan A. Menopause, hormone replacement therapy and cancer. Maturitas 2001; 39: 97–115.
Citing Literature
